References
1. Gradman J, Halken S. Preventive Effect of Allergen Immunotherapy on
Asthma and New Sensitizations. J Allergy Clin Immunol Pract. 2021.
2. Pfaar O, Agache I, Bonini M,et al. COVID-19 pandemic and allergen
immunotherapy - an EAACI survey. Allergy. 2021.
3. Chen YH, Lee MF, Lan JL, et al. Hypersensitivity to Forcipomyia
taiwana (biting midge): clinical analysis and identification of major
For t 1, For t 2 and For t 3 allergens. Allergy. 2005;60(12):1518-1523.
4. Chen YH, Hwang GY, Chen PC, et al. Molecular cloning and immunologic
characterization of for t 2: a major allergen from the biting midgeForcipomyia taiwana . Allergy. 2011;66(5):703-705.
5. Lee MF, Yang KJ, Wang NM, et al. The development of a murine model
for Forcipomyia taiwana (biting midge) allergy. PLoS One.
2014;9(3):e91871.
6. Lademann J, Richter H, Schanzer S, et al. Follicular penetration of
nanocarriers is an important penetration pathway for topically applied
drugs. Hautarzt. 2019;70(3):185-192.